Galderma

“You can’t be a company that wants to make people look better and not think about making people feel better.” Beauty x Medicine is back for Season 2 with a kick-off episode exploring the shared commitment to science-based innovation at Galderma and L’Oréal. Host Flemming Ornskov, MD, MPH and CEO of Galderma speaks to special guest Nicolas HIERONIMUS, CEO of L’Oréal, about the synergistic development of beauty and dermatology. The interconnected progress of both industries is best seen in the long-standing partnership between Galderma and L'Oréal, which recently deepened its investment in Galderma. Flemming and Nicolas discuss how sustained research investment has accelerated their growth trajectories and advanced both companies’ scientific leadership. From global markets to the latest consumer trends and tech advancements, the conversation reveals what it takes to remain at the forefront of innovation in periods of uncertainty. A self-described “marketeer at heart,” Nicolas has spent 39 years at L’Oréal. With experience spanning country management to product divisions, he also reflects on the moments that propelled him to the front of the world’s top beauty company. Beauty x Medicine uncovers the science behind beautiful, healthy skin and the trends shaping dermatology. Watch the latest episode to learn more from a leading voice in dermatology. #AdvancingDermatology #BeautyXMedicine

We are presenting new data from the longest extension study in prurigo nodularis at 2026 Winter Clinical™ Miami. The interim analysis explores the efficacy and safety of our treatment for prurigo nodularis up to three years.     This is part of our ongoing efforts to generate robust, long-term evidence in the treatment of chronic and debilitating skin conditions.     Learn more: https://lnkd.in/eYBGWNXv   #AdvancingDermatology #SkinSciencebyGalderma #ForInvestors 

Galderma announces the triple approval of its next-generation Restylane® syringe in the EU, the U.S., and Canada.    Developed in collaboration with aesthetic practitioners, the new syringe introduces enhanced ergonomics and improved injection control to support consistent, premium results.    These approvals demonstrate our strong heritage in Injectable Aesthetics, and our continued commitment to driving innovation in the field.    Read more: https://lnkd.in/eVPvwkCr

Cześć, Kraków! // Hello, Kraków! We’re excited to announce the opening of Galderma’s new Global Capability Center in Kraków, Poland. This strategic expansion brings a deeper IT-led focus which will help us scale technology solutions, including AI, globally and support our continued growth. The GCC will be located in Kraków’s tallest skyscraper, Unity Tower, a modern business hub home to top international companies and reflecting our premium brand and commitment to an exceptional employee experience. This new hub will support Galderma in our next phase of growth, providing a home base for our global support teams to advance our ambition to become the undisputed dermatology powerhouse. Read the full announcement: https://lnkd.in/eUxJWVzg #WeAreGalderma #AdvancingDermatology #GaldermaCareers

Just one week to go until we launch Season 2 of our video series Beauty x Medicine! This season, we have another exciting line-up of leading voices from across the spectrum of dermatology, starting with a special guest: we are pleased to welcome Nicolas HIERONIMUS, CEO of L'Oréal, for the first episode. In conversation with Galderma’s CEO, Flemming Ornskov, MD, MPH, Nicolas offers fascinating insights into today’s rapidly transforming market and how L’Oréal is staying ahead of the curve. Stay tuned for next week’s inaugural episode, and for more exclusive conversations as our CEO uncovers the cutting-edge of beauty and dermatology with top experts from around the world. #AdvancingDermatology #BeautyXMedicine

We are pleased to announce the appointment of Luigi La Corte as Chief Financial Officer. With over 30 years’ experience in international financial leadership across healthcare and consumer organizations, Luigi is ideally positioned to join Galderma as we work to become the world’s undisputed dermatology powerhouse. Luigi will join Galderma on April 1, 2026. He succeeds Thomas Dittrich, who will remain with Galderma through Q2 to ensure a seamless transition. Read the full press release: https://lnkd.in/eqWuRn6x #AdvancingDermatology #WeAreGalderma

We are proud to unveil ‘We Are All Sculptra®’, our new program featuring real patient journeys, each unfolding over two years.    Their unique stories capture the clinical and emotional impact of Sculptra, with authentic real-life perspectives revealing how aesthetic aspirations and personal experiences can shape a regenerative treatment journey.     Learn more: https://lnkd.in/e4_6wsPk   Always consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products. 

Happy International Day of Women and Girls in Science! Worldwide, women continue to be underrepresented in science, accounting for only 33% of researchers. In dermatology, female representation has increased significantly in the past 100 years, with women now making up nearly half of the workforce in the U.S., for example. Despite this, gender disparities persist in leadership roles across healthcare and academia. This gender imbalance limits the diversity of ideas, allows bias in research and risks excluding key perspectives. At Galderma, we foster a diverse and inclusive environment where all team members are heard. Over 55% of our global workforce is women, following in the footsteps of Drs. Robinson, Hirschler, Blackadder and Cummins. Today we celebrate all our colleagues who make healthcare and skin science a more welcoming field for women and girls. Together, we’re advancing dermatology for every skin story. #February11 #IDWGS #WomenInScience

Galderma continues to expand the versatility of the Restylane® portfolio in Japan with the launch of Restylane Defyne™ and Refyne™, the first OBT™-based hyaluronic acid injectables approved in the market. By bringing advanced flexibility, support, and natural movement, these launches enable treatment of a wider spectrum of patient and practitioner needs and underscore Galderma’s accelerating growth across the Japan & Asia Pacific region.    Read the full announcement:   https://lnkd.in/eptD_SAJ   Always consult a healthcare professional for individualized treatment recommendations and to discuss important safety information and risks associated with the use of the products. #AdvancingDermatology #SkinScienceByGalderma 

IMCAS 2026 has wrapped! What an inspiring several days in Paris where we connected with thousands of aesthetic professionals and shared the latest and greatest advancements in aesthetic science. Thank you, as always to our outstanding GAIN faculty and everyone who joined us at IMCAS. The Galderma Aesthetics Injector Network (GAIN) exists to elevate healthcare practitioners through trusted, high-quality education. Delivering best-in-class aesthetic treatments starts with empowering the professionals behind them and Galderma continues to invest in injector education worldwide. Join the community. Follow @gainbyGalderma on Instagram. #IMCAS2026 #SkinSciencebyGalderma